{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:09Z","timestamp":1792787289460,"version":"4.5.0"},"reference-count":31,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Joint Funding Program for Science and Technology Innovation in Fujian Province","award":["2023Y9268"],"award-info":[{"award-number":["2023Y9268"]}]},{"name":"National Key Research and Development Program","award":["2022YFC2407304"],"award-info":[{"award-number":["2022YFC2407304"]}]},{"name":"Major Science and Technology Projects of Fujian Province","award":["2021YZ036017"],"award-info":[{"award-number":["2021YZ036017"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503833, 62275050"],"award-info":[{"award-number":["82503833, 62275050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Scientific Foundation of Fuzhou Municipal Health Commission","award":["2021-S-wp1"],"award-info":[{"award-number":["2021-S-wp1"]}],"id":[{"id":"https:\/\/ror.org\/025qxt858","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Young and Middle-aged Talent of Fujian Provincial Health Commission","award":["2022GGA049"],"award-info":[{"award-number":["2022GGA049"]}]},{"name":"Key Clinical Specialty Discipline Construction Program of Fuzhou, Fujian","award":["20230101"],"award-info":[{"award-number":["20230101"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,10,13]]},"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The impact of nucleos(t)ide analogues (NAs) therapy on the long-term outcomes in chronic HBV infection individuals outside 2025 European Association for the Study of the Liver (EASL) strongly recommended treatment indications remains uncertain. We aimed to assess the association between NAs therapy and the risks of cirrhosis and hepatocellular carcinoma (HCC) in Chinese chronic HBV infection individuals outside these criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We analysed data from 30\u2009784 chronic HBV infection individuals across 12 centres in China. We categorised individuals outside 2025 EASL strongly recommended treatment criteria into four groups: (1) hepatitis B e antigen (HBeAg)-positive, high replicative (age &lt;30, HBV DNA \u22658 log\u2081\u2080IU\/mL, normal alanine aminotransferase (ALT), no\/mild fibrosis, no family history of liver cancer); (2) HBeAg-positive, impending phase transition (typically age \u226530, HBV DNA \u22656 log\u2081\u2080IU\/mL, normal ALT, no advanced fibrosis); (3) HBeAg-negative, low replicative (HBV DNA &lt;3.3 log\u2081\u2080IU\/mL, normal ALT, no\/mild fibrosis); (4) HBeAg-negative, high replicative, low-risk (HBV DNA 3.3\u20134.3 log\u2081\u2080IU\/mL, normal ALT, no\/mild fibrosis). The primary endpoints were the incidence of cirrhosis and HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Up to 5 years of follow-up (117\u2009814 person-years), we documented 635 incident cirrhosis and 164 HCC cases. In multivariable analyses, NA therapy significantly reduced risks of cirrhosis (HR 0.18, 95%\u2009CI 0.11 to 0.32) and HCC (HR 0.03, 95%\u2009CI 0.01 to 0.21) in Group 1, and cirrhosis (HR 0.50, 95%\u2009CI 0.41 to 0.61) and HCC (HR 0.25, 95%\u2009CI 0.16 to 0.41) in Group 2. No significant associations were observed in Groups 3 and 4. Findings were consistent in propensity score matching analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NAs therapy was associated with reduced risks of cirrhosis and HCC in HBeAg-positive individuals with high replicative or impending phase transition phenotypes, supporting the expansion of chronic HBV infection treatment criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-335449","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T08:25:21Z","timestamp":1761639921000},"page":"2232-2240","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-7744","authenticated-orcid":false,"given":"Shichuan","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Hepatopancreatobiliary Surgery, Wanyuan People\u2019s Hospital, Dazhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijing","family":"Tang","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, Zizhong County People\u2019s Hospital, Zizhong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Shen","sequence":"additional","affiliation":[{"name":"National Central Cancer Registry and State Key Laboratory of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wenjiang District People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Tang","sequence":"additional","affiliation":[{"name":"West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, Heze Hospital Affiliated of Shandong First Medical University, Heze, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Information Technology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luobin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeye","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatic Surgery II, Eastern Hepatobiliary Surgery Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Guizhou Maotai Hospital, Zunyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"You","sequence":"additional","affiliation":[{"name":"Biobank in Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mindong Hospital of Fujian Medical University, Fuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Ningde Hospital affiliated to Ningde Normal University, Ningde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Fuqing Hospital of Fujian Medical University, Fuqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Longyan First Hospital, Longyan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Zhangzhou Hospital of Fujian Medical University, Zhangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuxiong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiling","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, Beijing You\u2019an Hospital Affiliated to Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4981","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zeng","sequence":"additional","affiliation":[{"name":"National Central Cancer Registry and State Key Laboratory of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-5855","authenticated-orcid":false,"given":"Xiaolong","family":"Qi","sequence":"additional","affiliation":[{"name":"Liver Disease Center of Integrated Traditional Chinese and Western Medicine, Department of Radiology, Zhongda Hospital, Medical School, Southeast University Zhongda Hospital, Nanjing, Jiangsu, China"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Southeast University Zhongda Hospital, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6440-3664","authenticated-orcid":false,"given":"Yongyi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2026100702350701000_75.11.2232.1","unstructured":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva, 2024."},{"key":"2026100702350701000_75.11.2232.2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31694-5"},{"key":"2026100702350701000_75.11.2232.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01468-4"},{"key":"2026100702350701000_75.11.2232.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.010"},{"key":"2026100702350701000_75.11.2232.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"2026100702350701000_75.11.2232.7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/apt.13774","article-title":"Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients","volume":"44","author":"Lin","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2026100702350701000_75.11.2232.8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.iliver.2022.08.006","article-title":"Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosis","volume":"1","author":"Rao","year":"2022","journal-title":"ILIVER"},{"key":"2026100702350701000_75.11.2232.9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2468-1253(20)30307-1","article-title":"Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis","volume":"6","author":"Tan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"2026100702350701000_75.11.2232.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.042"},{"key":"2026100702350701000_75.11.2232.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.01.019"},{"key":"2026100702350701000_75.11.2232.13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jvh.13185","article-title":"The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria","volume":"26","author":"Sinn","year":"2019","journal-title":"J Viral Hepat"},{"key":"2026100702350701000_75.11.2232.14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000526933","article-title":"Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B","volume":"41","author":"Huang","year":"2023","journal-title":"Dig Dis"},{"key":"2026100702350701000_75.11.2232.15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314904"},{"key":"2026100702350701000_75.11.2232.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27382"},{"key":"2026100702350701000_75.11.2232.17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","author":"Razavi-Shearer","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.18","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.cgh.2022.10.035","article-title":"ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis","volume":"21","author":"Kim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.19","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.3350\/cmh.2024.0163","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis","volume":"30","author":"Jin","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"2026100702350701000_75.11.2232.20","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16097"},{"key":"2026100702350701000_75.11.2232.21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"2026100702350701000_75.11.2232.22","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466"},{"key":"2026100702350701000_75.11.2232.23","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"2026100702350701000_75.11.2232.24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2468-1253(24)00431-X","article-title":"Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial","volume":"10","author":"Lim","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.048"},{"key":"2026100702350701000_75.11.2232.26","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000196","article-title":"Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients","volume":"11","author":"Yeo","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"2026100702350701000_75.11.2232.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.11.030"},{"key":"2026100702350701000_75.11.2232.28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s43018-023-00618-8","article-title":"Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study","volume":"4","author":"Zeng","year":"2023","journal-title":"Nat Cancer"},{"key":"2026100702350701000_75.11.2232.29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cgh.2024.07.013","article-title":"Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"23","author":"Chung","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S2468-1253(20)30249-1","article-title":"Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis","volume":"5","author":"Tseng","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026100702350701000_75.11.2232.31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.19407","article-title":"Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis","volume":"5","author":"Tan","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-335449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:36:50Z","timestamp":1791365810000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-335449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/gutjnl-2025-335449"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-335449","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}